1. Project
  2. PsoraxPlan
  3. Organisations

A feasibility study on the development of Psorax35 as the first and only oral treatment for mild-to-moderate psoriasis with positive effects on co-morbidities.

Full project page

Organisations map overview


Powered by Chris Decubber BV